Header cover image

French (CAC) Pharma Industry Analysis

UpdatedFeb 25, 2024
DataAggregated Company Financials
Companies7
  • 7D3.3%
  • 3M3.9%
  • 1Y-0.6%
  • YTDn/a

Over the last 7 days, the Pharma industry has risen 3.3%, driven by gains from Sanofi of 3.8%. The industry has been flat over the past 12 months despite the gain this week. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the French Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 25 Feb 2024€126.1b€53.0b€6.3b20.4x20.1x2.4x
Tue, 23 Jan 2024€132.4b€52.2b€9.7b20.3x13.6x2.5x
Thu, 21 Dec 2023€126.1b€52.2b€9.7b18.5x13x2.4x
Sat, 18 Nov 2023€121.1b€52.2b€9.7b16.9x12.5x2.3x
Mon, 16 Oct 2023€144.0b€52.6b€9.3b17.4x15.5x2.7x
Wed, 13 Sep 2023€143.2b€52.6b€9.3b19.7x15.4x2.7x
Fri, 11 Aug 2023€138.2b€52.6b€9.3b21.5x14.9x2.6x
Sun, 09 Jul 2023€131.3b€52.6b€9.1b17.3x14.4x2.5x
Tue, 06 Jun 2023€133.5b€52.6b€9.1b15.6x14.6x2.5x
Thu, 04 May 2023€136.8b€52.6b€9.1b15.6x15x2.6x
Sat, 01 Apr 2023€138.8b€51.8b€9.2b15.4x15.2x2.7x
Mon, 27 Feb 2023€126.8b€51.7b€9.2b17.4x13.8x2.5x
Wed, 25 Jan 2023€125.0b€50.7b€7.4b18.5x17x2.5x
Fri, 23 Dec 2022€127.7b€50.7b€7.4b17x17.4x2.5x
Sun, 20 Nov 2022€121.9b€50.7b€7.4b16.8x16.6x2.4x
Tue, 18 Oct 2022€116.8b€48.4b€7.6b18.7x15.4x2.4x
Thu, 15 Sep 2022€116.1b€48.2b€7.6b22.6x15.3x2.4x
Sat, 13 Aug 2022€121.8b€48.2b€7.6b23.1x16.1x2.5x
Mon, 11 Jul 2022€138.8b€46.3b€7.5b22.4x18.5x3x
Wed, 08 Jun 2022€139.2b€46.3b€7.5b22.2x18.6x3x
Fri, 06 May 2022€138.0b€45.4b€7.5b23.1x18.4x3x
Sun, 03 Apr 2022€132.4b€44.2b€7.1b23.6x18.7x3x
Tue, 01 Mar 2022€130.7b€44.1b€7.1b19x18.5x3x
Thu, 27 Jan 2022€127.6b€43.2b€7.0b18.7x18.2x3x
Sat, 25 Dec 2021€122.6b€43.2b€7.0b21.5x17.5x2.8x
Mon, 22 Nov 2021€125.5b€43.2b€7.0b22.6x18x2.9x
Wed, 20 Oct 2021€116.8b€42.3b€6.6b20.1x17.7x2.8x
Fri, 17 Sep 2021€115.1b€42.2b€6.6b22.7x17.5x2.7x
Sun, 15 Aug 2021€122.0b€42.2b€6.6b20.7x18.5x2.9x
Thu, 10 Jun 2021€120.3b€41.6b€12.9b16.4x9.3x2.9x
Wed, 03 Mar 2021€105.0b€41.9b€13.0b12.4x8.1x2.5x
Price to Earnings Ratio

8.1x


Total Market Cap: €105.0bTotal Earnings: €13.0bTotal Revenue: €41.9bTotal Market Cap vs Earnings and Revenue0%0%0%
French Pharma Industry Price to Earnings3Y Average 15.7x202220232024
Current Industry PE
  • Investors are optimistic on the French Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 20.2x which is higher than its 3-year average PE of 15.7x.
  • The 3-year average PS ratio of 2.7x is higher than the industry's current PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 22% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does French Pharma compare with similar industries?

FR Market2.32%
Healthcare2.68%
Pharma3.32%
Pharma3.32%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SAN Sanofi€89.713.8%
+€3.6b
-0.2%PE20.7x
EAPI Euroapi€6.814.3%
+€26.8m
-55.7%PE20.8x
MEDCL MedinCell€8.992.2%
+€5.5m
5.6%PS18.3x
BOI Boiron€36.160.3%
+€2.1m
-14.0%PE13.2x
MLCOT Gour Medical€0.08113.3%
+€569.8k
150.0%PS1072540.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SAN

€89.71

Sanofi

7D

3.8%

1Y

-0.2%

EAPI

€6.81

Euroapi

7D

4.3%

1Y

-55.7%

MEDCL

€8.99

MedinCell

7D

2.2%

1Y

5.6%

IPN

€104.80

Ipsen

7D

-0.1%

1Y

-3.0%

AB

€3.35

AB Science

7D

-6.7%

1Y

-42.8%

VETO

€100.20

Vetoquinol

7D

-0.8%

1Y

24.5%

ALDVI

€1.34

Advicenne

7D

-18.1%

1Y

-64.0%

VIRP

€347.00

Virbac

7D

-0.6%

1Y

18.8%

MLCOT

€0.08

Gour Medical

7D

113.3%

1Y

150.0%

BOI

€36.16

Boiron

7D

0.3%

1Y

-14.0%